Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital
- PMID: 32970840
- PMCID: PMC7537241
- DOI: 10.1111/ijd.15180
Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital
Abstract
Background: COVID-19 cutaneous manifestations have been recently described and classified in five different clinical patterns, including acral erythema-edema (pseudo-chilblain), maculopapular exanthemas, vesicular eruptions, urticarial lesions, and livedo or necrosis.
Objectives: The objective of this study was to examine the skin of hospitalized patients with a confirmed diagnosis of COVID-19 disease and describe the real prevalence of skin manifestations.
Methods: A cross-sectional study, which included hospitalized patients in Cruces University Hospital from April 14-30, 2020, with a laboratory-confirmed diagnosis of COVID-19 (with polymerase chain reaction and/or serology tests), was conducted. Entire body surface examination was performed by experienced dermatologists to search for cutaneous manifestations related to COVID-19 disease.
Results: From a sample of 75 patients, 14 (18.7%) developed cutaneous manifestations possibly related to COVID-19. We found six patients with acral erythema-edema (pseudo-chilblain) (42.8%), four patients with maculopapular exanthemas (28.6%), two patients with urticarial lesions (14.3%), one patient with livedo reticularis-like lesions (7.15%), and one patient with vesicular eruption (7.15%).
Conclusions: Our study provides a more plausible relationship between the main cutaneous patterns and COVID-19 in hospitalized patients as all of them had a confirmatory laboratory test. Skin manifestations are frequent but mild with spontaneous resolution. These findings are nonspecific and can be similar to other viral infections and adverse drug reactions in hospitalized patients.
© 2020 the International Society of Dermatology.
Figures



Similar articles
-
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.Dermatology. 2021;237(1):1-12. doi: 10.1159/000512932. Epub 2020 Nov 24. Dermatology. 2021. PMID: 33232965 Free PMC article. Review.
-
Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19.J Am Acad Dermatol. 2021 Apr;84(4):946-952. doi: 10.1016/j.jaad.2020.12.046. Epub 2020 Dec 25. J Am Acad Dermatol. 2021. PMID: 33359476 Free PMC article.
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. Br J Dermatol. 2020. PMID: 32348545 Free PMC article.
-
Cutaneous manifestations of COVID-19 and COVID-19 vaccination.J Dermatol. 2023 Mar;50(3):280-289. doi: 10.1111/1346-8138.16651. Epub 2023 Jan 13. J Dermatol. 2023. PMID: 36636825
-
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.Viruses. 2021 Sep 24;13(10):1916. doi: 10.3390/v13101916. Viruses. 2021. PMID: 34696346 Free PMC article. Review.
Cited by
-
Type I Interferons in SARS-CoV-2 Cutaneous Infection: Is There a Role in Antiviral Defense?Int J Mol Sci. 2025 Jun 24;26(13):6049. doi: 10.3390/ijms26136049. Int J Mol Sci. 2025. PMID: 40649826 Free PMC article.
-
Maculopapular skin eruptions associated with Covid-19: A systematic review.Dermatol Ther. 2021 Mar;34(2):e14788. doi: 10.1111/dth.14788. Epub 2021 Feb 2. Dermatol Ther. 2021. PMID: 33481314 Free PMC article.
-
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.Dermatol Ther (Heidelb). 2021 Jun;11(3):695-705. doi: 10.1007/s13555-021-00526-8. Epub 2021 Apr 2. Dermatol Ther (Heidelb). 2021. PMID: 33811315 Free PMC article. Review.
-
Prevalence of skin manifestations in patients with COVID-19: a systematic review and meta-analysis.Front Med (Lausanne). 2024 Aug 21;11:1390775. doi: 10.3389/fmed.2024.1390775. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39234048 Free PMC article.
-
Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e183-e185. doi: 10.1111/jdv.17051. Epub 2020 Dec 21. J Eur Acad Dermatol Venereol. 2021. PMID: 33259091 Free PMC article. No abstract available.
References
-
- Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020; 323: 709–710. - PubMed
-
- European Centre for Disease Prevention and Control . Case definition and European surveillance for COVID‐19, as of 2 March 2020. 2020. https://www.ecdc.europa.eu/en/case‐definition‐and‐european‐surveillance‐.... Last accessed 9th May 2020.
-
- Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212–e213. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous